Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study June 2025 Congress News Read more
2023 August EHA 2023 Impact of TKI cessation on quality of life of CML patients across various age groups Read more
2023 August CongressUpdate Prognostic factors for maintenance of molecular remission after TKI discontinuation in CML pat... Read more
2023 July Clinical trials Efficacy of pirtobrutinib in CLL and SLL patients previously treated with covalent BTK inhibit... Read more
2023 June Medical Research Exa-cel infusion increases haemoglobin levels in β-thalassemia and sickle cell disease patie... Read more
Top
